A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia

Taylor Fields, Marc C. Patterson, Tatiana Brémovà-Ertl, G Belcher, Ian Billington, Grant C. Churchill, W. Davis, William Evans, Stephen Flint, U. Granzer,

Trials · 2021 · 34 citations · 23 references

DOIFull text

Open access

References

23